These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 31926582

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Secondary haemophagocytic lymphohistiocytosis due to checkpoint inhibitor therapy.
    Chin CK, Hall S, Green C, Van Hazel G, Spagnolo D, Cheah CY.
    Eur J Cancer; 2019 Jul; 115():84-87. PubMed ID: 31129384
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab.
    Hantel A, Gabster B, Cheng JX, Golomb H, Gajewski TF.
    J Immunother Cancer; 2018 Jul 16; 6(1):73. PubMed ID: 30012206
    [Abstract] [Full Text] [Related]

  • 6. Seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanoma.
    Gao CA, Weber UM, Peixoto AJ, Weiss SA.
    J Immunother Cancer; 2019 Oct 17; 7(1):262. PubMed ID: 31623673
    [Abstract] [Full Text] [Related]

  • 7. Delayed onset of neurosarcoidosis after concurrent ipilimumab/nivolumab therapy.
    Tan I, Malinzak M, Salama AKS.
    J Immunother Cancer; 2018 Jul 31; 6(1):77. PubMed ID: 30064495
    [Abstract] [Full Text] [Related]

  • 8. Dual checkpoint inhibitor-associated eosinophilic enteritis.
    Yang J, Lagana SM, Saenger YM, Carvajal RD.
    J Immunother Cancer; 2019 Nov 15; 7(1):310. PubMed ID: 31730503
    [Abstract] [Full Text] [Related]

  • 9. Complete ophthalmoplegia in Ipilmumab and Nivolumab combination treatment for metastatic melanoma.
    Alnabulsi R, Hussain A, DeAngelis D.
    Orbit; 2018 Oct 15; 37(5):381-384. PubMed ID: 29381409
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bullous pemphigoid induced by ipilimumab in a patient with metastatic malignant melanoma after unsuccessful treatment with nivolumab.
    Kuwatsuka Y, Iwanaga A, Kuwatsuka S, Okubo Y, Murayama N, Ishii N, Hashimoto T, Utani A.
    J Dermatol; 2018 Jan 15; 45(1):e21-e22. PubMed ID: 28944534
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bilateral anterior uveitis and unilateral facial palsy due to ipilimumab for metastatic melanoma in an individual with human leukocyte antigen DR4: A case report.
    Numata S, Iwata Y, Okumura R, Arima M, Kobayashi T, Watanabe S, Suzuki K, Horiguchi M, Sugiura K.
    J Dermatol; 2018 Jan 15; 45(1):113-114. PubMed ID: 28225147
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Type 1 diabetes in a melanoma patient treated with ipilimumab after nivolumab.
    Omodaka T, Kiniwa Y, Sato Y, Suwa M, Sato M, Yamaguchi T, Sato A, Miyake T, Okuyama R.
    J Dermatol; 2018 Oct 15; 45(10):e289-e290. PubMed ID: 29667767
    [No Abstract] [Full Text] [Related]

  • 19. Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy.
    Shiuan E, Beckermann KE, Ozgun A, Kelly C, McKean M, McQuade J, Thompson MA, Puzanov I, Greer JP, Rapisuwon S, Postow M, Davies MA, Eroglu Z, Johnson D.
    J Immunother Cancer; 2017 Oct 15; 5():8. PubMed ID: 28239462
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.